AnorMED

AnorMED is a chemistry-based drug discovery and development company. Their most advanced therapeutic candidate, AMD3100, is a stem cell mobilizer used in stem cell transplant cancer treatments.

History:

Founded in 1996.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Europe

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II) Therapeutics:Clinical late (III)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: